Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
about
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinomaPrognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infectionHepatic Enzyme Alterations in HIV Patients on Antiretroviral Therapy: A Case-Control Study in a Hospital Setting in GhanaSerum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.A comparative study of serum lipid contents in pre and post IFN-alpha treated acute hepatitis C patients.The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular CarcinomaHepatitis B virus X protein (HBx)-induced abnormalities of nucleic acid metabolism revealed by (1)H-NMR-based metabonomicsLiver Biochemistry During the Course of Influenza A/H1N1 Infection.The de ritis ratio: the test of time.Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.Prognostic value of serum γ-glutamyl transferase in unresectable hepatocellular carcinoma patients treated with transcatheter arterial chemoembolization combined with conformal radiotherapy.Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
P2860
Q28534409-2CC8B964-0D01-4D45-B837-894F6188EECFQ33580037-4E0B8138-E95B-496F-A830-8110F6190918Q34067936-9684A0BE-3F78-4EEC-9116-0133062EA7ABQ35565542-E9CBA72E-8F64-497D-A668-DC2C7061E99DQ35738818-156FCE78-9A42-4EFF-BA10-CE31634207B7Q35777325-8C994815-FAD9-48B8-B8A6-145D13D0CE12Q36092768-253B14AF-FE7F-40D1-B3CF-B225EE1A77DCQ36540674-A1BDA644-5E40-440B-BA85-C20CBC61E366Q36796330-9832751F-3CF5-4916-83F3-DAF820FC9862Q37311781-E5218EC3-D2B7-4FF0-A86A-C21E6D7A8B68Q37400943-C2997480-89CD-44B2-A302-3C06E067BF47Q40277999-CA9ED5B4-41CD-483D-A210-0A1C6FA7398DQ41518664-6EF135A3-53AB-4208-85E6-18D9F59259DBQ42931002-21623E65-D853-450E-A73C-FAF76E15E864Q50857582-57C3DA34-D858-46E2-A486-E35182BF1C6F
P2860
Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@ast
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@en
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@nl
type
label
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@ast
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@en
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@nl
prefLabel
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@ast
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@en
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@nl
P2093
P2860
P1433
P1476
Comprehensive analysis of comm ...... lar carcinoma in HBV patients.
@en
P2093
Bicui Chen
Hie-Won Hann
Hushan Yang
Jinliang Xing
Richard S Hann
Shaogui Wan
P2860
P304
P356
10.1371/JOURNAL.PONE.0047687
P407
P577
2012-10-24T00:00:00Z